Skip to main content
. 2015 Apr 24;3(4):929–935. doi: 10.3892/mco.2015.554

Figure 2.

Figure 2.

Kaplan-Meier plot for TTP in the 50 patients enrolled based on the severity of adverse reactions. The mTTP was 279 days for the patients with moderate or severe adverse events versus 141 days for the patients with mild or no adverse events, with a significant difference (χ2=5.079, P=0.024). TTP, time to disease progression.